Brean Murray Carret & Co. Starts JinkoSolar Holding Co., Ltd. (JKS) at Buy; Emerging Cost Leader in Transition from OEM to Branded Player
Get Alerts JKS Hot Sheet
Price: $16.62 -0.78%
Rating Summary:
11 Buy, 9 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
11 Buy, 9 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Brean Murray Carret & Co. initiates coverage on JinkoSolar Holding Co., Ltd. (NYSE: JKS) with a Buy. PT $32.
Brean analyst says, "JKS is rapidly emerging solar products manufacturer based in China with vertically integrated supply chain that includes ingots, wafers, cells, and modules...We believe our target price is in line with China-based peers, which are trading in the 4-6x range, and at a discount to its US-based peers, who are trading in the high-teen range."
For more ratings news on JinkoSolar Holding Co., Ltd. click here and for the rating history of JinkoSolar Holding Co., Ltd. click here.
Shares of JinkoSolar Holding Co., Ltd. closed at $27.20 yesterday.
Brean analyst says, "JKS is rapidly emerging solar products manufacturer based in China with vertically integrated supply chain that includes ingots, wafers, cells, and modules...We believe our target price is in line with China-based peers, which are trading in the 4-6x range, and at a discount to its US-based peers, who are trading in the high-teen range."
For more ratings news on JinkoSolar Holding Co., Ltd. click here and for the rating history of JinkoSolar Holding Co., Ltd. click here.
Shares of JinkoSolar Holding Co., Ltd. closed at $27.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Kanzhun Ltd. (BZ) at Neutral
- Needham Starts Pulse Biosciences (PLSE) at Buy
- Wedbush Starts Immunic Inc. (IMUX) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Brean Murray Carret & Co.Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share